COST-EFFECTIVENESS OF PHARMACOLOGIC TREATMENT OF OVERACTIVE BLADDER

被引：0
|
作者：
Malone, D. C. [1 ]
Armstrong, E. P. [1 ]
Bui, C. [2 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
[2] Astellas Pharma US Inc, Deerfield, IL USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.838
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A155 / A155
页数：1
相关论文
共 50 条
  • [31] OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
    Freemantle, Nick
    Khalaf, Kristin
    Loveman, Clara
    Stanisic, Sanja
    Gultyaev, Dmitry
    Lister, Johanna
    Drake, Marcus
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (07): : 911 - 921
  • [32] Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model
    Arlandis-Guzman, Salvador
    Errando-Smet, Carlos
    Trocio, Jeffrey
    Arumi, Daniel
    Rejas, Javier
    BMC UROLOGY, 2011, 11
  • [33] Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model
    Salvador Arlandis-Guzman
    Carlos Errando-Smet
    Jeffrey Trocio
    Daniel Arumi
    Javier Rejas
    BMC Urology, 11
  • [34] COST-EFFECTIVENESS OF SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER FROM A US PRIVATE PAYER AND MEDICARE ADVANTAGE PERSPECTIVE
    Ng, D. B.
    Wielage, R.
    Klein, T. M.
    Klein, R. W.
    Gooch, K.
    VALUE IN HEALTH, 2016, 19 (07) : A519 - A519
  • [35] COST-EFFECTIVENESS ANALYSIS OF SOLIFENACIN SUCCINATE VERSUS TROSPIUM CHLORIDE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN GERMANY
    Hart, W. M.
    Nazir, J.
    VALUE IN HEALTH, 2012, 15 (04) : A156 - A156
  • [36] COST-EFFECTIVENESS OF SACRAL NERVE STIMULATION IN REFRACTORY OVERACTIVE BLADDER: A CANADIAN PERSPECTIVE
    Sadri, H.
    Corcos, J.
    Dwyer, N.
    Gajewski, J.
    Gray, G.
    Hassouna, M.
    Robert, M.
    Tu, L.
    VALUE IN HEALTH, 2012, 15 (04) : A66 - A67
  • [37] COST-EFFECTIVENESS ANALYSIS OF SACRAL NEUROMODULATION IN REFRACTORY OVERACTIVE BLADDER : A CANADIAN PERSPECTIVE
    Tu, L.
    Hassouna, M. M.
    Gajewski, J.
    Robert, M.
    Grey, G. J.
    Dwyer, N. E.
    Corcos, J.
    Sadri, H.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S189 - S190
  • [38] A CANADIAN PERSPECTIVE OF COST-EFFECTIVENESS ANALYSIS OF SACRAL NEUROMODULATION IN REFRACTORY OVERACTIVE BLADDER
    Tu, L. M.
    Hassouna, M. M.
    Gajewski, J.
    Rob, M.
    Gray, G.
    Dwyer, N. E.
    Corcos, J.
    Sadri, H.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (06) : 764 - 765
  • [39] COST-EFFECTIVENESS STUDY OF DIAGNOSTIC TOOLS FOR THE EVALUATION OF FEMALE WITH OVERACTIVE BLADDER SYMPTOMS
    Lopez-Fando Lavalle, L.
    Jimenez Cidre, M. A.
    Esteban Fuertes, M.
    Prieto Chaparro, L.
    Arlandis Guzman, S.
    Franco de Castro, A.
    Salinas Casado, J.
    Castro-Diaz, D.
    Gutierrez Ruiz, C.
    Ifu, G.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (06) : 1007 - 1008
  • [40] Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective
    Murray, Brian
    Miles-Thomas, Jennifer
    Park, Amy J.
    Nguyen, Victor B.
    Tung, Amy
    Gillard, Patrick
    Lalla, Anjana
    Nitti, Victor W.
    Chermansky, Christopher J.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (02)
12345